MATINAS BIOPHARMA HOLDINGS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$789.71 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-08
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$5.42K.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$288.52K.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$94.19K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 32 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | -$789.71K 10-Q · filed 2017-08-08 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-08-08 | $0.00 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-08-08 | $0.00 10-Q · filed 2016-11-14 | -$22.93K derived: sum of 4 quarters · filed 2017-08-08 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | -$31.06K 10-Q · filed 2016-08-15 | -$22.93K derived: sum of 3 quarters · filed 2017-08-08 | -$37.45K derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | -$22.93K derived: sum of 2 quarters · filed 2017-03-31 | -$37.45K derived: sum of 3 quarters · filed 2017-03-31 | -$71.33K derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-12-31 | -$22.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$37.45K derived: sum of 2 quarters · filed 2017-03-31 | -$71.33K derived: sum of 3 quarters · filed 2017-03-31 | -$5.42K 10-K · filed 2017-03-31 | ||
| 2015-09-30 | -$14.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$48.40K derived: sum of 2 quarters · filed 2016-11-14 | $17.51K 10-Q · filed 2016-11-14 | $17.51K derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | -$33.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $32.02K 10-Q · filed 2016-08-15 | $32.02K derived: sum of 3 quarters · filed 2016-08-15 | $1.27K derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | $65.91K 10-Q · filed 2016-05-13 | $65.91K derived: sum of 2 quarters · filed 2016-05-13 | $35.16K derived: sum of 3 quarters · filed 2016-05-13 | -$29.33K derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$30.75K derived: sum of 2 quarters · filed 2016-03-30 | -$95.24K derived: sum of 3 quarters · filed 2016-03-30 | -$288.52K 10-K · filed 2016-03-30 | ||
| 2014-09-30 | -$30.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$95.24K derived: sum of 2 quarters · filed 2015-11-10 | -$288.52K 10-Q · filed 2015-11-10 | -$354.41K derived: sum of 4 quarters · filed 2015-11-10 | ||
| 2014-06-30 | -$64.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$257.77K 10-Q · filed 2015-08-13 | -$323.66K derived: sum of 3 quarters · filed 2015-08-13 | -$351.96K derived: sum of 4 quarters · filed 2015-08-13 | ||
| 2014-03-31 | -$193.28K 10-Q · filed 2015-05-15 | -$259.17K derived: sum of 2 quarters · filed 2015-05-15 | -$287.46K derived: sum of 3 quarters · filed 2015-05-15 | -$287.46K derived: sum of 4 quarters · filed 2015-05-15 | -$287.47K 10-Q · filed 2014-06-06 | |
| 2013-12-31 | -$65.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$94.19K derived: sum of 2 quarters · filed 2015-03-31 | -$94.19K derived: sum of 3 quarters · filed 2015-03-31 | -$94.19K 10-K · filed 2015-03-31 | ||
| 2013-09-30 | -$28.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$28.30K derived: sum of 2 quarters · filed 2014-11-14 | -$28.30K 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |